François-Xavier Danlos

13PUBLICATIONS
205CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 22, 2026
Overcoming Primary and Acquired Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies.

|Sep 24, 2025
Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade.

Romain Guitton, Ariane Laparra, Noemie Chanson

|Aug 06, 2025
Collagenous colitis in patients treated for cancer: role of immune checkpoint inhibitors. Clinical, histological and immunological features in 15 cases.

Mohamed-Amine Bani, Peggy Dartigues, Ranya Soufan

|Dec 31, 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Eden Sebbag, Kim Lauper, Juan Molina-Collada

|Nov 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer.

Filippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

Pageof 3

Frequent Collaborators

9 joint publications

Aurelien Marabelle

4 joint publications

Benjamin Besse

3 joint publications

Laurence Zitvogel

3 joint publications

Nathalie Chaput